Aligos Therapeutics (ALGS) Sale and Maturity of Investments (2020 - 2026)
Aligos Therapeutics' Sale and Maturity of Investments - Total came in at $25 million for Q2 2026, down 28.6% from the prior quarter.
Aligos Therapeutics (ALGS) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Sale and Maturity of Investments - Total was $127.5 million, up 41.7% from FY2024.
- Sale and Maturity of Investments - Total carries a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
- Going back by year, Sale and Maturity of Investments - Total was $90.01 million in FY2024 (+99.5%), $45.11 million in FY2023 (-42.8%), $78.86 million in FY2022 (+244.5%) and $22.89 million in FY2021 (-71.4%).
- The Q2 2026 figure represents the lowest quarterly Sale and Maturity of Investments - Total since Q1 2025.
- Business Quant data shows ALGS's Sale and Maturity of Investments - Total at $35 million (Q1 2026), $37.5 million (Q4 2025) and $70 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 37.50 Mn |
| Sep 30, 2025 | 70.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 19.98 Mn |
| Sep 30, 2024 | 30.08 Mn |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | -69,000.00 |
| Dec 31, 2023 | -44.92 Mn |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 25.00 Mn |
| Mar 31, 2023 | 20.00 Mn |
| Dec 31, 2022 | -42.75 Mn |
| Sep 30, 2022 | 37.45 Mn |
| Jun 30, 2022 | 5.49 Mn |
| Mar 31, 2022 | -248,000.00 |
| Dec 31, 2021 | -13.11 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 20.00 Mn |
Aligos Therapeutics Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();